文献速递美容整形创面修复

重组丝水凝胶作为新型真皮填充剂组分:临床前安全性与有效性研究

Recombinant Silk Hydrogel as a Novel Dermal Filler Component: Preclinical Safety and Efficacy Studies of a New Class of Tissue Fillers.
PubMed 文献 · Aesthet Surg J · 2020-01-01

本研究在啮齿类和猪两种动物模型中,比较含重组丝水凝胶的真皮填充剂与市售透明质酸填充剂的可注射性、重塑性、耐受性及植入后行为。结果显示丝水凝胶使填充剂适用性、剂量和組織分布更便利,无临床并发症,重组丝水凝胶作为安全便捷的组织填充成分具有基本适用性。

要点

  • 重组丝水凝胶可改善填充剂的可注射性与组织分布便利性。
  • 动物模型中未记录到归因于填充剂应用的临床并发症。
  • 丝水凝胶的剪切稀化特性可能带来更少疼痛与术后不适。

核心结论

  • 临床前数据表明重组丝水凝胶作为安全便捷的组织填充成分具有基本适用性。

研究设计与样本

  • 在啮齿类和猪两种动物模型中,比较含重组丝水凝胶的填充剂与市售透明质酸填充剂。
  • 重组丝水凝胶以单独制剂或与市售稳定透明质酸混合的形式进行测试。
  • 制剂经皮下给药后,对皮下储库进行临床、体积学和组织学监测数月。

主要发现

  • 丝水凝胶的存在使填充剂制剂的适用性、剂量和組織分布更为便利。
  • 未记录到归因于组织填充剂应用的临床并发症。
  • 高场磁共振成像等方法成功用于监测活体动物中填充剂储库的体积变化。

临床怎么用

  • 重组丝水凝胶的剪切稀化特性提示其可能实现更少疼痛的注射。
  • 该特性还提示注射后即刻舒适塑形和可忽略的术后不适。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyaluronic acid-based tissue fillers are commonly utilized in reconstructive surgery as well as for aesthetic augmentation. A new type of recombinant silk-based tissue filler might pose a beneficial alternative for surgeons and patients. OBJECTIVES: The aim of this study was to compare injectability, reshaping, tolerability, and postimplantation behavior of dermal filler preparations containing recombinant silk hydrogel with a commercially available hyaluronic acid filler in 2 different animal models. METHODS: Recombinant silk hydrogel as standalone preparation or as a mixture with commercial stabilized hyaluronic acid was tested in rodent and porcine animal models. The preparations were analyzed in detail and administered subdermally followed by clinical, volumetric, and histological monitoring of the subdermal depots over several months. RESULTS: Applicability, dosing, and tissue distribution of the filler preparations were facilitated in the presence of silk hydrogel. No clinical complications attributable to tissue filler application were recorded. State-of-the art methods, such as high-performance magnetic resonance imaging, were applied successfully to monitor the volumetric development of the filler depots in live animals. CONCLUSIONS: The preclinical data demonstrate the basic suitability of recombinant silk hydrogel as safe and convenient tissue filler ingredient. Due to its shear thinning properties, recombinant silk hydrogel has the potential for less painful application, comfortable aesthetic reshaping immediately after administration, and negligible postoperative discomfort.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Zeplin PH, Sukhova I, Kranz A, et al. Recombinant Silk Hydrogel as a Novel Dermal Filler Component: Preclinical Safety and Efficacy Studies of a New Class of Tissue Fillers. Aesthet Surg J. 2020. PMID: 32108867. doi:10.1093/asj/sjaa059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。